| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | store-operated calcium channel activity | 9.82e-07 | 12 | 34 | 3 | GO:0015279 | |
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 1.62e-06 | 14 | 34 | 3 | GO:0070679 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 1.02e-05 | 459 | 34 | 7 | GO:0005216 | |
| GeneOntologyMolecularFunction | channel activity | 2.42e-05 | 525 | 34 | 7 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 2.45e-05 | 526 | 34 | 7 | GO:0022803 | |
| GeneOntologyMolecularFunction | alcohol binding | 2.65e-05 | 102 | 34 | 4 | GO:0043178 | |
| GeneOntologyMolecularFunction | transporter activity | NPC1 SLC47A1 GRID1 GRID2 SLC9C1 TRPC7 ABCA9 TRPC3 TRPC6 KCNJ13 | 3.81e-05 | 1289 | 34 | 10 | GO:0005215 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 4.33e-05 | 793 | 34 | 8 | GO:0015075 | |
| GeneOntologyMolecularFunction | protein kinase activity | 5.67e-05 | 600 | 34 | 7 | GO:0004672 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | 1.16e-04 | 1180 | 34 | 9 | GO:0022857 | |
| GeneOntologyMolecularFunction | estrogen response element binding | 1.53e-04 | 11 | 34 | 2 | GO:0034056 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | 1.61e-04 | 709 | 34 | 7 | GO:0016773 | |
| GeneOntologyMolecularFunction | protein kinase C binding | 1.92e-04 | 66 | 34 | 3 | GO:0005080 | |
| GeneOntologyMolecularFunction | kinase activity | 2.54e-04 | 764 | 34 | 7 | GO:0016301 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 3.13e-04 | 193 | 34 | 4 | GO:0015276 | |
| GeneOntologyMolecularFunction | diacylglycerol-dependent serine/threonine kinase activity | 3.33e-04 | 16 | 34 | 2 | GO:0004697 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 3.38e-04 | 197 | 34 | 4 | GO:0022834 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | 3.48e-04 | 363 | 34 | 5 | GO:0106310 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 5.94e-04 | 627 | 34 | 6 | GO:0022890 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 8.03e-04 | 664 | 34 | 6 | GO:0008324 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | 8.72e-04 | 938 | 34 | 7 | GO:0016772 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | 8.86e-04 | 446 | 34 | 5 | GO:0004674 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 9.62e-04 | 27 | 34 | 2 | GO:0008066 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 1.07e-03 | 465 | 34 | 5 | GO:0046873 | |
| GeneOntologyMolecularFunction | calcium channel activity | 1.36e-03 | 129 | 34 | 3 | GO:0005262 | |
| GeneOntologyMolecularFunction | steroid binding | 1.49e-03 | 133 | 34 | 3 | GO:0005496 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 1.59e-03 | 758 | 34 | 6 | GO:0015318 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 2.14e-03 | 151 | 34 | 3 | GO:0015085 | |
| GeneOntologyMolecularFunction | 14-3-3 protein binding | 2.32e-03 | 42 | 34 | 2 | GO:0071889 | |
| GeneOntologyMolecularFunction | gated channel activity | 2.40e-03 | 334 | 34 | 4 | GO:0022836 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 2.64e-03 | 343 | 34 | 4 | GO:0005261 | |
| GeneOntologyMolecularFunction | potassium channel regulator activity | 4.24e-03 | 57 | 34 | 2 | GO:0015459 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 4.24e-03 | 57 | 34 | 2 | GO:1904315 | |
| GeneOntologyMolecularFunction | nuclear receptor activity | 4.68e-03 | 60 | 34 | 2 | GO:0004879 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 4.68e-03 | 60 | 34 | 2 | GO:0099529 | |
| GeneOntologyMolecularFunction | ligand-activated transcription factor activity | 4.84e-03 | 61 | 34 | 2 | GO:0098531 | |
| GeneOntologyMolecularFunction | general transcription initiation factor binding | 5.31e-03 | 64 | 34 | 2 | GO:0140296 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 5.47e-03 | 65 | 34 | 2 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 5.47e-03 | 65 | 34 | 2 | GO:0022824 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | 6.89e-03 | 1353 | 34 | 7 | GO:0004888 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 7.22e-03 | 75 | 34 | 2 | GO:0098960 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 7.60e-03 | 77 | 34 | 2 | GO:0005230 | |
| GeneOntologyMolecularFunction | virus receptor activity | 9.20e-03 | 85 | 34 | 2 | GO:0001618 | |
| GeneOntologyMolecularFunction | exogenous protein binding | 9.41e-03 | 86 | 34 | 2 | GO:0140272 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 1.26e-02 | 100 | 34 | 2 | GO:0030594 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SLC47A1 GRID1 GRID2 AKT1 AKT3 AKT2 SLC9C1 TRPC7 ZMPSTE24 TRPC3 TRPC6 KCNJ13 | 6.94e-07 | 1374 | 33 | 12 | GO:0006811 |
| GeneOntologyBiologicalProcess | cellular response to hormone stimulus | 1.44e-06 | 727 | 33 | 9 | GO:0032870 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | SLC47A1 AKT1 AKT3 AKT2 SLC9C1 TRPC7 ZMPSTE24 TRPC3 TRPC6 KCNJ13 | 8.39e-06 | 1157 | 33 | 10 | GO:0006812 |
| GeneOntologyBiologicalProcess | negative regulation of long-chain fatty acid import across plasma membrane | 1.49e-05 | 4 | 33 | 2 | GO:0010748 | |
| GeneOntologyBiologicalProcess | negative regulation of long-chain fatty acid import into cell | 1.49e-05 | 4 | 33 | 2 | GO:0140213 | |
| GeneOntologyBiologicalProcess | metal ion transport | 1.92e-05 | 1000 | 33 | 9 | GO:0030001 | |
| GeneOntologyBiologicalProcess | gland development | 2.37e-05 | 558 | 33 | 7 | GO:0048732 | |
| GeneOntologyBiologicalProcess | response to hormone | 2.66e-05 | 1042 | 33 | 9 | GO:0009725 | |
| GeneOntologyBiologicalProcess | cellular response to peptide hormone stimulus | 2.77e-05 | 381 | 33 | 6 | GO:0071375 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | 3.04e-05 | 230 | 33 | 5 | GO:0098739 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to membrane | 3.50e-05 | 237 | 33 | 5 | GO:1905475 | |
| GeneOntologyBiologicalProcess | positive regulation of transport | 3.55e-05 | 1081 | 33 | 9 | GO:0051050 | |
| GeneOntologyBiologicalProcess | positive regulation of sodium ion transport | 4.10e-05 | 42 | 33 | 3 | GO:0010765 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | 4.53e-05 | 1115 | 33 | 9 | GO:0034220 | |
| GeneOntologyBiologicalProcess | regulation of long-chain fatty acid import across plasma membrane | 5.19e-05 | 7 | 33 | 2 | GO:0010746 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA-binding transcription factor activity | 5.55e-05 | 261 | 33 | 5 | GO:0051091 | |
| GeneOntologyBiologicalProcess | cellular response to oxygen-containing compound | 5.92e-05 | 1450 | 33 | 10 | GO:1901701 | |
| GeneOntologyBiologicalProcess | positive regulation of monoatomic ion transport | 6.07e-05 | 266 | 33 | 5 | GO:0043270 | |
| GeneOntologyBiologicalProcess | cellular response to insulin stimulus | 6.63e-05 | 271 | 33 | 5 | GO:0032869 | |
| GeneOntologyBiologicalProcess | positive regulation of transmembrane transport | 6.86e-05 | 273 | 33 | 5 | GO:0034764 | |
| GeneOntologyBiologicalProcess | positive regulation of D-glucose import | 6.95e-05 | 50 | 33 | 3 | GO:0046326 | |
| GeneOntologyBiologicalProcess | peripheral nervous system myelin maintenance | 8.87e-05 | 9 | 33 | 2 | GO:0032287 | |
| GeneOntologyBiologicalProcess | regulation of long-chain fatty acid import into cell | 8.87e-05 | 9 | 33 | 2 | GO:0140212 | |
| GeneOntologyBiologicalProcess | regulation of TOR signaling | 1.14e-04 | 158 | 33 | 4 | GO:0032006 | |
| GeneOntologyBiologicalProcess | peptidyl-serine phosphorylation | 1.19e-04 | 307 | 33 | 5 | GO:0018105 | |
| GeneOntologyBiologicalProcess | response to nitrogen compound | 1.25e-04 | 1272 | 33 | 9 | GO:1901698 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane neurotransmitter receptor levels | 1.32e-04 | 164 | 33 | 4 | GO:0099072 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid transport | 1.35e-04 | 11 | 33 | 2 | GO:2000192 | |
| GeneOntologyBiologicalProcess | positive regulation of D-glucose transmembrane transport | 1.39e-04 | 63 | 33 | 3 | GO:0010828 | |
| GeneOntologyBiologicalProcess | peptidyl-serine modification | 1.43e-04 | 319 | 33 | 5 | GO:0018209 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein tyrosine kinase signaling pathway | 1.49e-04 | 747 | 33 | 7 | GO:0007169 | |
| GeneOntologyBiologicalProcess | protein localization to plasma membrane | 1.53e-04 | 324 | 33 | 5 | GO:0072659 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to cell periphery | 1.55e-04 | 171 | 33 | 4 | GO:1904375 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid import across plasma membrane | 1.62e-04 | 12 | 33 | 2 | GO:0015911 | |
| GeneOntologyBiologicalProcess | response to peptide hormone | 1.72e-04 | 530 | 33 | 6 | GO:0043434 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane potential | 1.88e-04 | 180 | 33 | 4 | GO:0060078 | |
| GeneOntologyBiologicalProcess | TOR signaling | 1.92e-04 | 181 | 33 | 4 | GO:0031929 | |
| GeneOntologyBiologicalProcess | response to insulin | 1.97e-04 | 342 | 33 | 5 | GO:0032868 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation involved in prostate gland development | 2.57e-04 | 15 | 33 | 2 | GO:0060742 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transport | 2.72e-04 | 577 | 33 | 6 | GO:0043269 | |
| GeneOntologyBiologicalProcess | regulation of D-glucose import | 2.92e-04 | 81 | 33 | 3 | GO:0046324 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane transport | 3.03e-04 | 589 | 33 | 6 | GO:0034762 | |
| GeneOntologyBiologicalProcess | mammary gland epithelium development | 3.25e-04 | 84 | 33 | 3 | GO:0061180 | |
| GeneOntologyBiologicalProcess | regulation of cytosolic calcium ion concentration | 3.25e-04 | 84 | 33 | 3 | GO:0051480 | |
| GeneOntologyBiologicalProcess | negative regulation of apoptotic process | 3.28e-04 | 1133 | 33 | 8 | GO:0043066 | |
| GeneOntologyBiologicalProcess | single fertilization | 3.33e-04 | 209 | 33 | 4 | GO:0007338 | |
| GeneOntologyBiologicalProcess | positive regulation of glycogen biosynthetic process | 3.74e-04 | 18 | 33 | 2 | GO:0045725 | |
| GeneOntologyBiologicalProcess | myelin maintenance | 3.74e-04 | 18 | 33 | 2 | GO:0043217 | |
| GeneOntologyBiologicalProcess | negative regulation of programmed cell death | 4.09e-04 | 1171 | 33 | 8 | GO:0043069 | |
| GeneOntologyBiologicalProcess | mammary gland epithelial cell differentiation | 4.17e-04 | 19 | 33 | 2 | GO:0060644 | |
| GeneOntologyBiologicalProcess | behavior | 4.37e-04 | 891 | 33 | 7 | GO:0007610 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid import into cell | 4.63e-04 | 20 | 33 | 2 | GO:0044539 | |
| GeneOntologyBiologicalProcess | membrane organization | 5.10e-04 | 914 | 33 | 7 | GO:0061024 | |
| GeneOntologyBiologicalProcess | protein localization to cell periphery | 5.18e-04 | 422 | 33 | 5 | GO:1990778 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | 5.37e-04 | 922 | 33 | 7 | GO:0098662 | |
| GeneOntologyBiologicalProcess | glucan metabolic process | 5.59e-04 | 101 | 33 | 3 | GO:0044042 | |
| GeneOntologyBiologicalProcess | regulation of sodium ion transport | 5.59e-04 | 101 | 33 | 3 | GO:0002028 | |
| GeneOntologyBiologicalProcess | fatty acid transmembrane transport | 5.62e-04 | 22 | 33 | 2 | GO:1902001 | |
| GeneOntologyBiologicalProcess | D-glucose import | 5.75e-04 | 102 | 33 | 3 | GO:0046323 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | 6.10e-04 | 942 | 33 | 7 | GO:0098655 | |
| GeneOntologyBiologicalProcess | regulation of D-glucose transmembrane transport | 6.26e-04 | 105 | 33 | 3 | GO:0010827 | |
| GeneOntologyBiologicalProcess | chemical homeostasis | 6.29e-04 | 1249 | 33 | 8 | GO:0048878 | |
| GeneOntologyBiologicalProcess | positive regulation of glycogen metabolic process | 6.70e-04 | 24 | 33 | 2 | GO:0070875 | |
| GeneOntologyBiologicalProcess | regulation of fatty acid beta-oxidation | 6.70e-04 | 24 | 33 | 2 | GO:0031998 | |
| GeneOntologyBiologicalProcess | regulation of DNA-binding transcription factor activity | 6.86e-04 | 449 | 33 | 5 | GO:0051090 | |
| GeneOntologyBiologicalProcess | organ growth | 7.15e-04 | 256 | 33 | 4 | GO:0035265 | |
| GeneOntologyBiologicalProcess | lipid import into cell | 7.28e-04 | 25 | 33 | 2 | GO:0140354 | |
| GeneOntologyBiologicalProcess | peptidyl-amino acid modification | 7.53e-04 | 976 | 33 | 7 | GO:0018193 | |
| GeneOntologyBiologicalProcess | negative regulation of autophagy | 7.55e-04 | 112 | 33 | 3 | GO:0010507 | |
| GeneOntologyBiologicalProcess | protein localization to membrane | 7.85e-04 | 705 | 33 | 6 | GO:0072657 | |
| GeneOntologyBiologicalProcess | fertilization | 7.90e-04 | 263 | 33 | 4 | GO:0009566 | |
| GeneOntologyBiologicalProcess | peptidyl-threonine phosphorylation | 8.15e-04 | 115 | 33 | 3 | GO:0018107 | |
| GeneOntologyBiologicalProcess | positive regulation of fibroblast migration | 8.50e-04 | 27 | 33 | 2 | GO:0010763 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 9.33e-04 | 275 | 33 | 4 | GO:0006814 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | 9.60e-04 | 1017 | 33 | 7 | GO:0098660 | |
| GeneOntologyBiologicalProcess | peptidyl-threonine modification | 1.04e-03 | 125 | 33 | 3 | GO:0018210 | |
| GeneOntologyBiologicalProcess | regulation of metal ion transport | 1.04e-03 | 493 | 33 | 5 | GO:0010959 | |
| GeneOntologyBiologicalProcess | polysaccharide metabolic process | 1.06e-03 | 126 | 33 | 3 | GO:0005976 | |
| GeneOntologyBiologicalProcess | cellular response to nitrogen compound | 1.10e-03 | 752 | 33 | 6 | GO:1901699 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to plasma membrane | 1.11e-03 | 128 | 33 | 3 | GO:1903076 | |
| GeneOntologyBiologicalProcess | response to organic cyclic compound | 1.14e-03 | 1048 | 33 | 7 | GO:0014070 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to membrane | 1.16e-03 | 130 | 33 | 3 | GO:1905477 | |
| GeneOntologyBiologicalProcess | excitatory postsynaptic potential | 1.16e-03 | 130 | 33 | 3 | GO:0060079 | |
| GeneOntologyBiologicalProcess | negative regulation of organic acid transport | 1.19e-03 | 32 | 33 | 2 | GO:0032891 | |
| GeneOntologyBiologicalProcess | calcium ion transport | 1.20e-03 | 509 | 33 | 5 | GO:0006816 | |
| GeneOntologyBiologicalProcess | regulation of glucose metabolic process | 1.27e-03 | 134 | 33 | 3 | GO:0010906 | |
| GeneOntologyBiologicalProcess | peripheral nervous system axon ensheathment | 1.27e-03 | 33 | 33 | 2 | GO:0032292 | |
| GeneOntologyBiologicalProcess | myelination in peripheral nervous system | 1.27e-03 | 33 | 33 | 2 | GO:0022011 | |
| GeneOntologyBiologicalProcess | prostate gland epithelium morphogenesis | 1.27e-03 | 33 | 33 | 2 | GO:0060740 | |
| GeneOntologyBiologicalProcess | import into cell | 1.32e-03 | 1074 | 33 | 7 | GO:0098657 | |
| GeneOntologyBiologicalProcess | prostate gland morphogenesis | 1.35e-03 | 34 | 33 | 2 | GO:0060512 | |
| GeneOntologyBiologicalProcess | positive regulation of glial cell proliferation | 1.35e-03 | 34 | 33 | 2 | GO:0060252 | |
| GeneOntologyBiologicalProcess | epidermal growth factor receptor signaling pathway | 1.41e-03 | 139 | 33 | 3 | GO:0007173 | |
| GeneOntologyBiologicalProcess | negative regulation of macroautophagy | 1.43e-03 | 35 | 33 | 2 | GO:0016242 | |
| GeneOntologyBiologicalProcess | localization within membrane | 1.49e-03 | 798 | 33 | 6 | GO:0051668 | |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | 1.52e-03 | 1430 | 33 | 8 | GO:0044093 | |
| GeneOntologyBiologicalProcess | cellular response to estrogen stimulus | 1.60e-03 | 37 | 33 | 2 | GO:0071391 | |
| GeneOntologyBiologicalProcess | anoikis | 1.60e-03 | 37 | 33 | 2 | GO:0043276 | |
| GeneOntologyCellularComponent | PAR polarity complex | 3.61e-05 | 6 | 33 | 2 | GO:0120157 | |
| GeneOntologyCellularComponent | glutamatergic synapse | 2.38e-04 | 817 | 33 | 7 | GO:0098978 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 2.95e-04 | 378 | 33 | 5 | GO:0034702 | |
| GeneOntologyCellularComponent | cell leading edge | 1.05e-03 | 500 | 33 | 5 | GO:0031252 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 1.28e-03 | 523 | 33 | 5 | GO:1902495 | |
| GeneOntologyCellularComponent | transporter complex | 1.60e-03 | 550 | 33 | 5 | GO:1990351 | |
| GeneOntologyCellularComponent | nuclear envelope | 1.73e-03 | 560 | 33 | 5 | GO:0005635 | |
| GeneOntologyCellularComponent | cell-cell junction | 2.19e-03 | 591 | 33 | 5 | GO:0005911 | |
| GeneOntologyCellularComponent | somatodendritic compartment | 2.63e-03 | 1228 | 33 | 7 | GO:0036477 | |
| GeneOntologyCellularComponent | cell cortex | 2.66e-03 | 371 | 33 | 4 | GO:0005938 | |
| GeneOntologyCellularComponent | ciliary basal body | 3.55e-03 | 195 | 33 | 3 | GO:0036064 | |
| GeneOntologyCellularComponent | nuclear inner membrane | 3.91e-03 | 59 | 33 | 2 | GO:0005637 | |
| MousePheno | increased circulating pituitary hormone level | 3.35e-06 | 110 | 30 | 5 | MP:0005117 | |
| MousePheno | increased pituitary hormone level | 7.06e-06 | 128 | 30 | 5 | MP:0003973 | |
| MousePheno | mammary gland alveolar hyperplasia | 1.33e-05 | 3 | 30 | 2 | MP:0001884 | |
| MousePheno | abnormal circulating pituitary hormone level | 2.96e-05 | 172 | 30 | 5 | MP:0005116 | |
| MousePheno | increased hormone level | 4.46e-05 | 641 | 30 | 8 | MP:0014454 | |
| MousePheno | increased circulating luteinizing hormone level | 5.57e-05 | 35 | 30 | 3 | MP:0001751 | |
| MousePheno | increased luteinizing hormone level | 7.15e-05 | 38 | 30 | 3 | MP:0005133 | |
| MousePheno | abnormal pituitary hormone level | 8.37e-05 | 214 | 30 | 5 | MP:0003965 | |
| MousePheno | small amniotic cavity | 9.29e-05 | 7 | 30 | 2 | MP:0012104 | |
| MousePheno | decreased neuron number | 1.25e-04 | 376 | 30 | 6 | MP:0008948 | |
| MousePheno | increased circulating hormone level | 1.77e-04 | 578 | 30 | 7 | MP:0014456 | |
| MousePheno | abnormal Purkinje cell dendrite morphology | 2.54e-04 | 58 | 30 | 3 | MP:0008572 | |
| MousePheno | increased circulating gonadotropin level | 3.40e-04 | 64 | 30 | 3 | MP:0003362 | |
| MousePheno | abnormal head fold morphology | 3.40e-04 | 64 | 30 | 3 | MP:0011257 | |
| MousePheno | abnormal luteinizing hormone level | 3.40e-04 | 64 | 30 | 3 | MP:0003969 | |
| MousePheno | abnormal neuron number | 3.55e-04 | 456 | 30 | 6 | MP:0008946 | |
| MousePheno | decreased Purkinje cell number | 3.89e-04 | 67 | 30 | 3 | MP:0000880 | |
| MousePheno | abnormal Purkinje cell number | 4.25e-04 | 69 | 30 | 3 | MP:0000878 | |
| Domain | Pkinase_C | 6.15e-09 | 37 | 34 | 5 | IPR017892 | |
| Domain | Pkinase_C | 1.19e-08 | 42 | 34 | 5 | PF00433 | |
| Domain | AGC-kinase_C | 5.26e-08 | 56 | 34 | 5 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 5.26e-08 | 56 | 34 | 5 | PS51285 | |
| Domain | S_TK_X | 5.26e-08 | 56 | 34 | 5 | SM00133 | |
| Domain | TRP_dom | 1.10e-07 | 6 | 34 | 3 | IPR013555 | |
| Domain | TRP_2 | 1.10e-07 | 6 | 34 | 3 | PF08344 | |
| Domain | TRPC_channel | 1.92e-07 | 7 | 34 | 3 | IPR002153 | |
| Domain | TRP_channel | 9.00e-07 | 11 | 34 | 3 | IPR004729 | |
| Domain | PKC | 3.22e-06 | 2 | 34 | 2 | IPR012233 | |
| Domain | PROTEIN_KINASE_ATP | 1.57e-05 | 459 | 34 | 7 | PS00107 | |
| Domain | Prot_kinase_dom | 2.35e-05 | 489 | 34 | 7 | IPR000719 | |
| Domain | PROTEIN_KINASE_DOM | 2.48e-05 | 493 | 34 | 7 | PS50011 | |
| Domain | Kinase-like_dom | 4.54e-05 | 542 | 34 | 7 | IPR011009 | |
| Domain | Ion_trans_dom | 5.30e-05 | 114 | 34 | 4 | IPR005821 | |
| Domain | Ion_trans | 5.30e-05 | 114 | 34 | 4 | PF00520 | |
| Domain | Protein_kinase_ATP_BS | 5.58e-05 | 379 | 34 | 6 | IPR017441 | |
| Domain | PB1 | 2.89e-04 | 14 | 34 | 2 | SM00666 | |
| Domain | PB1 | 2.89e-04 | 14 | 34 | 2 | PS51745 | |
| Domain | PB1 | 2.89e-04 | 14 | 34 | 2 | PF00564 | |
| Domain | PB1_dom | 2.89e-04 | 14 | 34 | 2 | IPR000270 | |
| Domain | Ser/Thr_kinase_AS | 4.38e-04 | 357 | 34 | 5 | IPR008271 | |
| Domain | S_TKc | 4.49e-04 | 359 | 34 | 5 | SM00220 | |
| Domain | PROTEIN_KINASE_ST | 4.66e-04 | 362 | 34 | 5 | PS00108 | |
| Domain | Iontro_rcpt | 4.83e-04 | 18 | 34 | 2 | IPR001320 | |
| Domain | Lig_chan | 4.83e-04 | 18 | 34 | 2 | PF00060 | |
| Domain | Lig_chan-Glu_bd | 4.83e-04 | 18 | 34 | 2 | PF10613 | |
| Domain | PBPe | 4.83e-04 | 18 | 34 | 2 | SM00079 | |
| Domain | Iono_rcpt_met | 4.83e-04 | 18 | 34 | 2 | IPR001508 | |
| Domain | Glu/Gly-bd | 4.83e-04 | 18 | 34 | 2 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 4.83e-04 | 18 | 34 | 2 | SM00918 | |
| Domain | Pkinase | 5.88e-04 | 381 | 34 | 5 | PF00069 | |
| Domain | DAG/PE-bd | 6.61e-04 | 21 | 34 | 2 | IPR020454 | |
| Domain | ANF_receptor | 2.06e-03 | 37 | 34 | 2 | PF01094 | |
| Domain | ANF_lig-bd_rcpt | 2.06e-03 | 37 | 34 | 2 | IPR001828 | |
| Domain | Peripla_BP_I | 2.29e-03 | 39 | 34 | 2 | IPR028082 | |
| Domain | zf-C4 | 3.17e-03 | 46 | 34 | 2 | PF00105 | |
| Domain | NUCLEAR_REC_DBD_1 | 3.17e-03 | 46 | 34 | 2 | PS00031 | |
| Domain | Znf_hrmn_rcpt | 3.17e-03 | 46 | 34 | 2 | IPR001628 | |
| Domain | ZnF_C4 | 3.17e-03 | 46 | 34 | 2 | SM00399 | |
| Domain | NUCLEAR_REC_DBD_2 | 3.17e-03 | 46 | 34 | 2 | PS51030 | |
| Domain | - | 3.30e-03 | 47 | 34 | 2 | 1.10.565.10 | |
| Domain | HOLI | 3.44e-03 | 48 | 34 | 2 | SM00430 | |
| Domain | Nucl_hrmn_rcpt_lig-bd | 3.44e-03 | 48 | 34 | 2 | IPR000536 | |
| Domain | Hormone_recep | 3.44e-03 | 48 | 34 | 2 | PF00104 | |
| Domain | C1_1 | 4.82e-03 | 57 | 34 | 2 | PF00130 | |
| Domain | - | 4.82e-03 | 57 | 34 | 2 | 3.30.50.10 | |
| Pathway | REACTOME_EXTRA_NUCLEAR_ESTROGEN_SIGNALING | 4.54e-09 | 71 | 28 | 6 | MM15590 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_PI3K_SIGNALING_PATHWAY_N01350 | 6.10e-09 | 12 | 28 | 4 | M47798 | |
| Pathway | REACTOME_EXTRA_NUCLEAR_ESTROGEN_SIGNALING | 6.35e-09 | 75 | 28 | 6 | M27874 | |
| Pathway | KEGG_MEDICUS_VARIANT_LOSS_OF_NKX3_1_TO_PI3K_SIGNALING_PATHWAY | 7.00e-08 | 5 | 28 | 3 | M48999 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_NUCLEAR_EVENTS_DOWNSTREAM_OF_ESR_MEMBRANE_SIGNALING | 1.29e-07 | 24 | 28 | 4 | M27952 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MAGI_PTEN_SIGNALING_PATHWAY | 1.40e-07 | 6 | 28 | 3 | M47523 | |
| Pathway | PID_INSULIN_GLUCOSE_PATHWAY | 1.81e-07 | 26 | 28 | 4 | M247 | |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | 2.00e-07 | 133 | 28 | 6 | MM15529 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PI3K_TO_PI3K_SIGNALING_PATHWAY | 2.44e-07 | 7 | 28 | 3 | M47407 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACH_CHRN_PI3K_SIGNALING_PATHWAY | 2.44e-07 | 7 | 28 | 3 | M47790 | |
| Pathway | PID_NEPHRIN_NEPH1_PATHWAY | 3.78e-07 | 31 | 28 | 4 | M193 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PI3K_SIGNALING_PATHWAY | 3.90e-07 | 8 | 28 | 3 | M47399 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PI3K_SIGNALING_PATHWAY | 3.90e-07 | 8 | 28 | 3 | M47394 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PI3K_SIGNALING_PATHWAY | 3.90e-07 | 8 | 28 | 3 | M47395 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_PI3K_SIGNALING_PATHWAY | 3.90e-07 | 8 | 28 | 3 | M47404 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_PI3K_SIGNALING_PATHWAY | 3.90e-07 | 8 | 28 | 3 | M47405 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P4_PR_PI3K_SIGNALING_PATHWAY | 3.90e-07 | 8 | 28 | 3 | M47803 | |
| Pathway | REACTOME_RUNX2_REGULATES_GENES_INVOLVED_IN_CELL_MIGRATION | 3.90e-07 | 8 | 28 | 3 | M27806 | |
| Pathway | KEGG_MEDICUS_VARIANT_TGFA_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 3.90e-07 | 8 | 28 | 3 | M47482 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 3.90e-07 | 8 | 28 | 3 | M47498 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_RET_TO_PI3K_SIGNALING_PATHWAY | 3.90e-07 | 8 | 28 | 3 | M47715 | |
| Pathway | PID_MET_PATHWAY | 4.32e-07 | 79 | 28 | 5 | M48 | |
| Pathway | WP_GLIOBLASTOMA_SIGNALING | 5.53e-07 | 83 | 28 | 5 | M39637 | |
| Pathway | REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION | 5.84e-07 | 261 | 28 | 7 | M1077 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_PI3K_SIGNALING_PATHWAY | 5.85e-07 | 9 | 28 | 3 | M47397 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_SIGNALING_PATHWAY | 5.85e-07 | 9 | 28 | 3 | M47392 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KRAS_NRAS_TO_PI3K_SIGNALING_PATHWAY | 5.85e-07 | 9 | 28 | 3 | M47391 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_PI3K_SIGNALING_PATHWAY | 5.85e-07 | 9 | 28 | 3 | M47402 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MEMBRANE_INITIATED_PROGESTERONE_SIGNALING_PATHWAY | 5.85e-07 | 9 | 28 | 3 | M47802 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_MET_TO_PI3K_SIGNALING_PATHWAY | 5.85e-07 | 9 | 28 | 3 | M47490 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGFA_EGFR_PI3K_SIGNALING_PATHWAY | 5.85e-07 | 9 | 28 | 3 | M47481 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_NUCLEAR_EVENTS_DOWNSTREAM_OF_ESR_MEMBRANE_SIGNALING | 5.85e-07 | 9 | 28 | 3 | MM15666 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ICOSLG_ICOS_PI3K_SIGNALING_PATHWAY | 5.85e-07 | 9 | 28 | 3 | M47972 | |
| Pathway | REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN_1_SIGNALING | 8.34e-07 | 10 | 28 | 3 | M27330 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGFR_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 8.34e-07 | 10 | 28 | 3 | M47400 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HGF_MET_PI3K_SIGNALING_PATHWAY | 8.34e-07 | 10 | 28 | 3 | M47401 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CD80_CD86_CD28_PI3K_SIGNALING_PATHWAY | 8.34e-07 | 10 | 28 | 3 | M47615 | |
| Pathway | REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_NUCLEUS | 8.34e-07 | 10 | 28 | 3 | M27095 | |
| Pathway | REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_NUCLEUS | 8.34e-07 | 10 | 28 | 3 | MM14778 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NICOTINE_NNK_TO_PI3K_SIGNALING_PATHWAY | 1.15e-06 | 11 | 28 | 3 | M47797 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KITLG_KIT_PI3K_SIGNALING_PATHWAY | 1.15e-06 | 11 | 28 | 3 | M47403 | |
| Pathway | KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_PI3K_SIGNALING_PATHWAY | 1.15e-06 | 11 | 28 | 3 | M47406 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF2_IGF1R_PI3K_SIGNALING_PATHWAY | 1.15e-06 | 11 | 28 | 3 | M47484 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EREG_EGFR_PI3K_SIGNALING_PATHWAY | 1.15e-06 | 11 | 28 | 3 | M47499 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NRG_ERBB4_PI3K_SIGNALING_PATHWAY | 1.15e-06 | 11 | 28 | 3 | M47756 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_PI3K_SIGNALING_PATHWAY_N01339 | 1.15e-06 | 11 | 28 | 3 | M47791 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AREG_EGFR_PI3K_SIGNALING_PATHWAY | 1.15e-06 | 11 | 28 | 3 | M47501 | |
| Pathway | KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 1.53e-06 | 12 | 28 | 3 | M47393 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY | 1.53e-06 | 12 | 28 | 3 | M47558 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY | 1.53e-06 | 12 | 28 | 3 | M47559 | |
| Pathway | REACTOME_SARS_COV_2_TARGETS_HOST_INTRACELLULAR_SIGNALLING_AND_REGULATORY_PATHWAYS | 1.53e-06 | 12 | 28 | 3 | M45022 | |
| Pathway | REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS | 1.53e-06 | 12 | 28 | 3 | MM15657 | |
| Pathway | REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS | 1.53e-06 | 12 | 28 | 3 | M27939 | |
| Pathway | REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL | 1.53e-06 | 12 | 28 | 3 | MM14777 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING | 1.53e-06 | 12 | 28 | 3 | MM14550 | |
| Pathway | REACTOME_NETRIN_1_SIGNALING | 1.60e-06 | 44 | 28 | 4 | M875 | |
| Pathway | PID_INSULIN_PATHWAY | 1.60e-06 | 44 | 28 | 4 | M16 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 1.62e-06 | 103 | 28 | 5 | MM14752 | |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | 1.68e-06 | 191 | 28 | 6 | MM15586 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 1.87e-06 | 106 | 28 | 5 | M27077 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PI3K_SIGNALING_PATHWAY | 1.98e-06 | 13 | 28 | 3 | M47398 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGF1R_PI3K_SIGNALING_PATHWAY | 1.98e-06 | 13 | 28 | 3 | M47603 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING | 1.98e-06 | 13 | 28 | 3 | M549 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 1.98e-06 | 13 | 28 | 3 | MM14553 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_PI3K_SIGNALING_PATHWAY | 2.52e-06 | 14 | 28 | 3 | M47390 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ASSOCIATION_WITH_CO_FACTORS | 2.52e-06 | 14 | 28 | 3 | MM15341 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ASSOCIATION_WITH_CO_FACTORS | 2.52e-06 | 14 | 28 | 3 | M27638 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGFR_PI3K_NFKB_SIGNALING_PATHWAY | 2.52e-06 | 14 | 28 | 3 | M47467 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_NFKB_SIGNALING_PATHWAY | 2.52e-06 | 14 | 28 | 3 | M47536 | |
| Pathway | REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL | 2.52e-06 | 14 | 28 | 3 | M3862 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_PI3K_SIGNALING_PATHWAY | 3.14e-06 | 15 | 28 | 3 | M47389 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RELN_VLDLR_PI3K_SIGNALING_PATHWAY | 3.14e-06 | 15 | 28 | 3 | M47663 | |
| Pathway | REACTOME_ACTIVATION_OF_BAD_AND_TRANSLOCATION_TO_MITOCHONDRIA | 3.14e-06 | 15 | 28 | 3 | M26902 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_PI3K_SIGNALING_PATHWAY | 3.14e-06 | 15 | 28 | 3 | M47475 | |
| Pathway | WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS | 3.14e-06 | 15 | 28 | 3 | M48306 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_BCAP_CD19_PI3K_SIGNALING_PATHWAY | 3.14e-06 | 15 | 28 | 3 | M47971 | |
| Pathway | WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER | 3.68e-06 | 54 | 28 | 4 | M42568 | |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | 3.82e-06 | 220 | 28 | 6 | M27794 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 3.86e-06 | 16 | 28 | 3 | M26945 | |
| Pathway | WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES | 4.68e-06 | 17 | 28 | 3 | M48086 | |
| Pathway | SA_PTEN_PATHWAY | 4.68e-06 | 17 | 28 | 3 | M12771 | |
| Pathway | SA_TRKA_RECEPTOR | 4.68e-06 | 17 | 28 | 3 | M18895 | |
| Pathway | WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA | 5.26e-06 | 59 | 28 | 4 | M39750 | |
| Pathway | KEGG_TIGHT_JUNCTION | 5.52e-06 | 132 | 28 | 5 | M11355 | |
| Pathway | KEGG_INSULIN_SIGNALING_PATHWAY | 6.62e-06 | 137 | 28 | 5 | M18155 | |
| Pathway | WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION | 6.66e-06 | 19 | 28 | 3 | M39370 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PP2A_AKT_SIGNALING_PATHWAY | 6.66e-06 | 19 | 28 | 3 | M47525 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 8.24e-06 | 66 | 28 | 4 | MM15925 | |
| Pathway | SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES | 8.76e-06 | 67 | 28 | 4 | M295 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS | 9.11e-06 | 21 | 28 | 3 | M14966 | |
| Pathway | REACTOME_CTLA4_INHIBITORY_SIGNALING | 9.11e-06 | 21 | 28 | 3 | M5876 | |
| Pathway | REACTOME_CTLA4_INHIBITORY_SIGNALING | 9.11e-06 | 21 | 28 | 3 | MM14996 | |
| Pathway | REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION | 9.32e-06 | 257 | 28 | 6 | MM15454 | |
| Pathway | REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING | 1.05e-05 | 22 | 28 | 3 | M13897 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION | 1.05e-05 | 22 | 28 | 3 | MM15656 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CD80_CD86_CTLA4_PP2A_SIGNALING_PATHWAY | 1.05e-05 | 22 | 28 | 3 | M47919 | |
| Pathway | WP_SIGNAL_TRANSDUCTION_OF_S1P_RECEPTOR | 1.21e-05 | 23 | 28 | 3 | MM15952 | |
| Pathway | WP_SILDENAFIL_TREATMENT | 1.21e-05 | 23 | 28 | 3 | M46455 | |
| Pathway | REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING | 1.21e-05 | 23 | 28 | 3 | MM14993 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_VGPCR_TO_GNB_G_PI3K_AKT_SIGNALING_PATHWAY | 1.38e-05 | 24 | 28 | 3 | M47460 | |
| Pubmed | 4.29e-12 | 5 | 35 | 4 | 9512493 | ||
| Pubmed | A WD-FYVE protein binds to the kinases Akt and PKCzeta/lambda. | 4.29e-12 | 5 | 35 | 4 | 16792529 | |
| Pubmed | Signalling crosstalk in FGF2-mediated protection of endothelial cells from HIV-gp120. | 4.01e-11 | 25 | 35 | 5 | 15689238 | |
| Pubmed | 9.34e-10 | 3 | 35 | 3 | 17912369 | ||
| Pubmed | Differential activation of AKT isoforms by growth factors in human myotubes. | 9.34e-10 | 3 | 35 | 3 | 37879895 | |
| Pubmed | Differential prognostic values of the three AKT isoforms in acute myeloid leukemia. | 9.34e-10 | 3 | 35 | 3 | 38528080 | |
| Pubmed | 9.34e-10 | 3 | 35 | 3 | 15987444 | ||
| Pubmed | 9.34e-10 | 3 | 35 | 3 | 19825827 | ||
| Pubmed | 9.34e-10 | 3 | 35 | 3 | 16540465 | ||
| Pubmed | Molecular alterations in AKT1, AKT2 and AKT3 detected in breast and prostatic cancer by FISH. | 9.34e-10 | 3 | 35 | 3 | 20102399 | |
| Pubmed | Distinct roles of the three Akt isoforms in lactogenic differentiation and involution. | 9.34e-10 | 3 | 35 | 3 | 18561256 | |
| Pubmed | 9.34e-10 | 3 | 35 | 3 | 28526717 | ||
| Pubmed | Differential effects of Akt isoforms on somatic cell reprogramming. | 9.34e-10 | 3 | 35 | 3 | 25037569 | |
| Pubmed | 9.34e-10 | 3 | 35 | 3 | 38396845 | ||
| Pubmed | AKT isoforms have distinct hippocampal expression and roles in synaptic plasticity. | 9.34e-10 | 3 | 35 | 3 | 29173281 | |
| Pubmed | 9.34e-10 | 3 | 35 | 3 | 21590431 | ||
| Pubmed | 9.34e-10 | 3 | 35 | 3 | 29235817 | ||
| Pubmed | 9.34e-10 | 3 | 35 | 3 | 34296180 | ||
| Pubmed | Sex differences in the mechanism of Met5-enkephalin-induced cardioprotection: role of PI3K/Akt. | 9.34e-10 | 3 | 35 | 3 | 17982014 | |
| Pubmed | Opposing functions of Akt isoforms in lung tumor initiation and progression. | 9.34e-10 | 3 | 35 | 3 | 24722238 | |
| Pubmed | 9.34e-10 | 3 | 35 | 3 | 24039187 | ||
| Pubmed | 9.34e-10 | 3 | 35 | 3 | 16923958 | ||
| Pubmed | 9.34e-10 | 3 | 35 | 3 | 17202487 | ||
| Pubmed | 9.34e-10 | 3 | 35 | 3 | 26953242 | ||
| Pubmed | 9.34e-10 | 3 | 35 | 3 | 23929892 | ||
| Pubmed | 9.34e-10 | 3 | 35 | 3 | 19805051 | ||
| Pubmed | 9.34e-10 | 3 | 35 | 3 | 25233414 | ||
| Pubmed | 9.34e-10 | 3 | 35 | 3 | 21555366 | ||
| Pubmed | 9.34e-10 | 3 | 35 | 3 | 32796067 | ||
| Pubmed | 9.34e-10 | 3 | 35 | 3 | 25811375 | ||
| Pubmed | Akt/Protein kinase B is required for lymphatic network formation, remodeling, and valve development. | 9.34e-10 | 3 | 35 | 3 | 20724596 | |
| Pubmed | Akt Regulates Axon Wrapping and Myelin Sheath Thickness in the PNS. | 9.34e-10 | 3 | 35 | 3 | 27098694 | |
| Pubmed | 9.34e-10 | 3 | 35 | 3 | 28931550 | ||
| Pubmed | 9.34e-10 | 3 | 35 | 3 | 10579998 | ||
| Pubmed | 9.34e-10 | 3 | 35 | 3 | 20398329 | ||
| Pubmed | 9.34e-10 | 3 | 35 | 3 | 33325370 | ||
| Pubmed | The Akt isoforms are present at distinct subcellular locations. | 9.34e-10 | 3 | 35 | 3 | 20018949 | |
| Pubmed | 9.34e-10 | 3 | 35 | 3 | 24247267 | ||
| Pubmed | 9.34e-10 | 3 | 35 | 3 | 17895832 | ||
| Pubmed | Reduction of Akt2 expression inhibits chemotaxis signal transduction in human breast cancer cells. | 9.34e-10 | 3 | 35 | 3 | 18353613 | |
| Pubmed | Molecular cloning, expression and characterization of the human serine/threonine kinase Akt-3. | 9.34e-10 | 3 | 35 | 3 | 10491192 | |
| Pubmed | 9.34e-10 | 3 | 35 | 3 | 17210696 | ||
| Pubmed | Role for Akt3/protein kinase Bgamma in attainment of normal brain size. | 9.34e-10 | 3 | 35 | 3 | 15713641 | |
| Pubmed | 1.55e-09 | 16 | 35 | 4 | 21624358 | ||
| Pubmed | Protein kinase Akt2/PKBβ is involved in blastomere proliferation of preimplantation mouse embryos. | 3.73e-09 | 4 | 35 | 3 | 31552693 | |
| Pubmed | 3.73e-09 | 4 | 35 | 3 | 23749168 | ||
| Pubmed | Differential effects of protein kinase B/Akt isoforms on glucose homeostasis and islet mass. | 3.73e-09 | 4 | 35 | 3 | 19933838 | |
| Pubmed | 3.73e-09 | 4 | 35 | 3 | 21242979 | ||
| Pubmed | 3.73e-09 | 4 | 35 | 3 | 30017393 | ||
| Pubmed | 3.73e-09 | 4 | 35 | 3 | 21953448 | ||
| Pubmed | 3.73e-09 | 4 | 35 | 3 | 19435822 | ||
| Pubmed | 3.73e-09 | 4 | 35 | 3 | 21507933 | ||
| Pubmed | Conditional inactivation of Akt three isoforms causes tau hyperphosphorylation in the brain. | 3.73e-09 | 4 | 35 | 3 | 26227811 | |
| Pubmed | 3.73e-09 | 4 | 35 | 3 | 17942896 | ||
| Pubmed | 3.73e-09 | 4 | 35 | 3 | 30567482 | ||
| Pubmed | 3.73e-09 | 4 | 35 | 3 | 21763505 | ||
| Pubmed | The E3 ligase TTC3 facilitates ubiquitination and degradation of phosphorylated Akt. | 9.32e-09 | 5 | 35 | 3 | 20059950 | |
| Pubmed | 9.32e-09 | 5 | 35 | 3 | 27938661 | ||
| Pubmed | 9.32e-09 | 5 | 35 | 3 | 21261756 | ||
| Pubmed | 9.32e-09 | 5 | 35 | 3 | 26855332 | ||
| Pubmed | Unequal contribution of Akt isoforms in the double-negative to double-positive thymocyte transition. | 9.32e-09 | 5 | 35 | 3 | 17442925 | |
| Pubmed | 9.32e-09 | 5 | 35 | 3 | 22814751 | ||
| Pubmed | Leptin deficiency and beta-cell dysfunction underlie type 2 diabetes in compound Akt knockout mice. | 9.32e-09 | 5 | 35 | 3 | 19289493 | |
| Pubmed | Platelet-derived growth factor protects neurons against gp120-mediated toxicity. | 9.32e-09 | 5 | 35 | 3 | 18300076 | |
| Pubmed | TRPC channels are necessary mediators of pathologic cardiac hypertrophy. | 9.32e-09 | 5 | 35 | 3 | 20351294 | |
| Pubmed | 9.32e-09 | 5 | 35 | 3 | 25246356 | ||
| Pubmed | 9.32e-09 | 5 | 35 | 3 | 14500673 | ||
| Pubmed | Brown fat organogenesis and maintenance requires AKT1 and AKT2. | 9.32e-09 | 5 | 35 | 3 | 30833219 | |
| Pubmed | 9.32e-09 | 5 | 35 | 3 | 36640312 | ||
| Pubmed | Spontaneous Hepatocellular Carcinoma after the Combined Deletion of Akt Isoforms. | 9.32e-09 | 5 | 35 | 3 | 26996309 | |
| Pubmed | Neutrophil AKT2 regulates heterotypic cell-cell interactions during vascular inflammation. | 1.86e-08 | 6 | 35 | 3 | 24642468 | |
| Pubmed | mTORC2-AKT signaling to ATP-citrate lyase drives brown adipogenesis and de novo lipogenesis. | 1.86e-08 | 6 | 35 | 3 | 31996678 | |
| Pubmed | KCTD20, a relative of BTBD10, is a positive regulator of Akt. | 1.86e-08 | 6 | 35 | 3 | 24156551 | |
| Pubmed | 1.86e-08 | 6 | 35 | 3 | 14749824 | ||
| Pubmed | 1.86e-08 | 6 | 35 | 3 | 23746211 | ||
| Pubmed | 1.86e-08 | 6 | 35 | 3 | 12176997 | ||
| Pubmed | Stabilization of phosphofructokinase 1 platelet isoform by AKT promotes tumorigenesis. | 1.86e-08 | 6 | 35 | 3 | 29038421 | |
| Pubmed | Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival. | 1.86e-08 | 6 | 35 | 3 | 10869418 | |
| Pubmed | Akt Regulates Sox10 Expression to Control Oligodendrocyte Differentiation via Phosphorylating FoxO1. | 1.86e-08 | 6 | 35 | 3 | 34385359 | |
| Pubmed | 1.86e-08 | 6 | 35 | 3 | 15616007 | ||
| Pubmed | 1.86e-08 | 6 | 35 | 3 | 23673657 | ||
| Pubmed | 1.86e-08 | 6 | 35 | 3 | 22107784 | ||
| Pubmed | Differential regulation of Akt kinase isoforms by the members of the TCL1 oncogene family. | 1.86e-08 | 6 | 35 | 3 | 11707444 | |
| Pubmed | 1.86e-08 | 6 | 35 | 3 | 21606541 | ||
| Pubmed | Protein kinase B alpha/Akt1 regulates placental development and fetal growth. | 1.86e-08 | 6 | 35 | 3 | 12783884 | |
| Pubmed | 1.86e-08 | 6 | 35 | 3 | 18160256 | ||
| Pubmed | AKT-dependent HspB1 (Hsp27) activity in epidermal differentiation. | 1.86e-08 | 6 | 35 | 3 | 17439945 | |
| Pubmed | 1.86e-08 | 6 | 35 | 3 | 20186503 | ||
| Pubmed | 2.31e-08 | 30 | 35 | 4 | 24472646 | ||
| Pubmed | MxA, a member of the dynamin superfamily, interacts with the ankyrin-like repeat domain of TRPC. | 3.26e-08 | 7 | 35 | 3 | 15757897 | |
| Pubmed | 3.26e-08 | 7 | 35 | 3 | 23968884 | ||
| Pubmed | 3.26e-08 | 7 | 35 | 3 | 19261608 | ||
| Pubmed | 3.26e-08 | 7 | 35 | 3 | 23604117 | ||
| Pubmed | 3.26e-08 | 7 | 35 | 3 | 36592529 | ||
| Pubmed | Functional role of TRPC proteins in vivo: lessons from TRPC-deficient mouse models. | 3.26e-08 | 7 | 35 | 3 | 15336983 | |
| Pubmed | 3.26e-08 | 7 | 35 | 3 | 23811558 | ||
| Pubmed | 3.26e-08 | 7 | 35 | 3 | 17634444 | ||
| Pubmed | 3.26e-08 | 7 | 35 | 3 | 16287854 | ||
| Pubmed | 3.26e-08 | 7 | 35 | 3 | 21697490 | ||
| Pubmed | 3.26e-08 | 7 | 35 | 3 | 32350291 | ||
| Interaction | TRPC7 interactions | 7.97e-08 | 6 | 33 | 3 | int:TRPC7 | |
| Interaction | AKT1S1 interactions | 2.07e-07 | 32 | 33 | 4 | int:AKT1S1 | |
| Interaction | MX1 interactions | 2.72e-06 | 60 | 33 | 4 | int:MX1 | |
| Interaction | RPS6KB1 interactions | 3.39e-06 | 143 | 33 | 5 | int:RPS6KB1 | |
| Interaction | BTBD10 interactions | 6.03e-06 | 22 | 33 | 3 | int:BTBD10 | |
| Interaction | TMPRSS12 interactions | 6.93e-06 | 23 | 33 | 3 | int:TMPRSS12 | |
| Interaction | GNB1 interactions | 9.32e-06 | 307 | 33 | 6 | int:GNB1 | |
| Interaction | AKT3 interactions | 1.10e-05 | 85 | 33 | 4 | int:AKT3 | |
| Interaction | PDPK1 interactions | 1.86e-05 | 203 | 33 | 5 | int:PDPK1 | |
| Interaction | TRPC3 interactions | 2.11e-05 | 33 | 33 | 3 | int:TRPC3 | |
| Interaction | EIF4A1 interactions | 2.12e-05 | 355 | 33 | 6 | int:EIF4A1 | |
| Interaction | ITPR3 interactions | 2.24e-05 | 211 | 33 | 5 | int:ITPR3 | |
| Interaction | GSN interactions | 2.29e-05 | 212 | 33 | 5 | int:GSN | |
| Interaction | MTCP1 interactions | 3.88e-05 | 6 | 33 | 2 | int:MTCP1 | |
| Interaction | CD44 interactions | 4.07e-05 | 239 | 33 | 5 | int:CD44 | |
| Interaction | TFF1 interactions | 4.09e-05 | 41 | 33 | 3 | int:TFF1 | |
| Interaction | SGK2 interactions | 4.72e-05 | 43 | 33 | 3 | int:SGK2 | |
| Interaction | TTC3 interactions | 4.87e-05 | 124 | 33 | 4 | int:TTC3 | |
| Interaction | AKT1 interactions | 5.20e-05 | 617 | 33 | 7 | int:AKT1 | |
| Interaction | EMC1 interactions | 5.29e-05 | 418 | 33 | 6 | int:EMC1 | |
| Interaction | TPM4 interactions | 5.96e-05 | 259 | 33 | 5 | int:TPM4 | |
| Interaction | CDC37 interactions | 6.88e-05 | 645 | 33 | 7 | int:CDC37 | |
| Interaction | MME interactions | 7.38e-05 | 138 | 33 | 4 | int:MME | |
| Interaction | ITPR1 interactions | 8.02e-05 | 141 | 33 | 4 | int:ITPR1 | |
| Interaction | SRC interactions | 8.26e-05 | 664 | 33 | 7 | int:SRC | |
| Interaction | AKT2 interactions | 8.48e-05 | 143 | 33 | 4 | int:AKT2 | |
| Interaction | SEL1L interactions | 8.94e-05 | 145 | 33 | 4 | int:SEL1L | |
| Interaction | IRS1 interactions | 8.94e-05 | 145 | 33 | 4 | int:IRS1 | |
| Interaction | PFKP interactions | 9.22e-05 | 284 | 33 | 5 | int:PFKP | |
| Interaction | SHANK2 interactions | 9.90e-05 | 55 | 33 | 3 | int:SHANK2 | |
| Interaction | PPP1CB interactions | 9.99e-05 | 469 | 33 | 6 | int:PPP1CB | |
| Interaction | STEAP4 interactions | 1.16e-04 | 10 | 33 | 2 | int:STEAP4 | |
| Interaction | RPE interactions | 1.16e-04 | 58 | 33 | 3 | int:RPE | |
| Interaction | CSNK2A1 interactions | 1.20e-04 | 956 | 33 | 8 | int:CSNK2A1 | |
| Interaction | TRIB3 interactions | 1.31e-04 | 160 | 33 | 4 | int:TRIB3 | |
| Interaction | NIPSNAP2 interactions | 1.34e-04 | 161 | 33 | 4 | int:NIPSNAP2 | |
| Interaction | AFAP1 interactions | 1.35e-04 | 61 | 33 | 3 | int:AFAP1 | |
| Interaction | TCL1A interactions | 1.35e-04 | 61 | 33 | 3 | int:TCL1A | |
| Interaction | CD55 interactions | 1.42e-04 | 62 | 33 | 3 | int:CD55 | |
| Interaction | HSP90AA1 interactions | 1.42e-04 | 1263 | 33 | 9 | int:HSP90AA1 | |
| Interaction | OTUD1 interactions | 1.65e-04 | 170 | 33 | 4 | int:OTUD1 | |
| Interaction | PRKG1 interactions | 1.78e-04 | 67 | 33 | 3 | int:PRKG1 | |
| Interaction | APPL1 interactions | 2.15e-04 | 182 | 33 | 4 | int:APPL1 | |
| Interaction | PIAS1 interactions | 2.54e-04 | 353 | 33 | 5 | int:PIAS1 | |
| Interaction | VHL interactions | 2.64e-04 | 561 | 33 | 6 | int:VHL | |
| Interaction | SP1 interactions | 2.96e-04 | 365 | 33 | 5 | int:SP1 | |
| Interaction | TRPC6 interactions | 3.24e-04 | 82 | 33 | 3 | int:TRPC6 | |
| Interaction | DDOST interactions | 3.36e-04 | 375 | 33 | 5 | int:DDOST | |
| Interaction | PLEKHO1 interactions | 3.48e-04 | 84 | 33 | 3 | int:PLEKHO1 | |
| Interaction | SP3 interactions | 3.48e-04 | 84 | 33 | 3 | int:SP3 | |
| Interaction | CLIP3 interactions | 3.48e-04 | 17 | 33 | 2 | int:CLIP3 | |
| Interaction | BLVRA interactions | 3.73e-04 | 86 | 33 | 3 | int:BLVRA | |
| Interaction | CASP3 interactions | 4.12e-04 | 216 | 33 | 4 | int:CASP3 | |
| Interaction | DAPK3 interactions | 4.13e-04 | 89 | 33 | 3 | int:DAPK3 | |
| Interaction | RNH1 interactions | 4.41e-04 | 220 | 33 | 4 | int:RNH1 | |
| Interaction | CAMK2D interactions | 4.56e-04 | 222 | 33 | 4 | int:CAMK2D | |
| Interaction | CCNT1 interactions | 4.80e-04 | 225 | 33 | 4 | int:CCNT1 | |
| Interaction | FARP2 interactions | 4.84e-04 | 94 | 33 | 3 | int:FARP2 | |
| Interaction | EIF4EBP1 interactions | 4.84e-04 | 94 | 33 | 3 | int:EIF4EBP1 | |
| Interaction | RPS6KA1 interactions | 5.05e-04 | 228 | 33 | 4 | int:RPS6KA1 | |
| Interaction | EMC2 interactions | 5.10e-04 | 411 | 33 | 5 | int:EMC2 | |
| Interaction | PRKCZ interactions | 5.16e-04 | 412 | 33 | 5 | int:PRKCZ | |
| Interaction | FKBP5 interactions | 5.27e-04 | 414 | 33 | 5 | int:FKBP5 | |
| Interaction | KCTD20 interactions | 5.36e-04 | 21 | 33 | 2 | int:KCTD20 | |
| Interaction | GRID2 interactions | 5.88e-04 | 22 | 33 | 2 | int:GRID2 | |
| Interaction | GRID1 interactions | 5.88e-04 | 22 | 33 | 2 | int:GRID1 | |
| Interaction | FYN interactions | 6.33e-04 | 431 | 33 | 5 | int:FYN | |
| Interaction | PNRC1 interactions | 6.44e-04 | 23 | 33 | 2 | int:PNRC1 | |
| Interaction | TRPC4 interactions | 6.44e-04 | 23 | 33 | 2 | int:TRPC4 | |
| Interaction | LMAN2 interactions | 6.69e-04 | 105 | 33 | 3 | int:LMAN2 | |
| Interaction | SLC2A1 interactions | 6.81e-04 | 247 | 33 | 4 | int:SLC2A1 | |
| Interaction | TRPC5 interactions | 7.02e-04 | 24 | 33 | 2 | int:TRPC5 | |
| Interaction | PSMD1 interactions | 7.09e-04 | 442 | 33 | 5 | int:PSMD1 | |
| Interaction | MAP4K4 interactions | 7.56e-04 | 254 | 33 | 4 | int:MAP4K4 | |
| Interaction | GRHL2 interactions | 7.62e-04 | 25 | 33 | 2 | int:GRHL2 | |
| Interaction | FAF2 interactions | 7.77e-04 | 451 | 33 | 5 | int:FAF2 | |
| Interaction | TYSND1 interactions | 8.25e-04 | 26 | 33 | 2 | int:TYSND1 | |
| Interaction | FKBP1A interactions | 8.28e-04 | 113 | 33 | 3 | int:FKBP1A | |
| Interaction | TPM1 interactions | 8.61e-04 | 263 | 33 | 4 | int:TPM1 | |
| Interaction | PLCG1 interactions | 8.73e-04 | 264 | 33 | 4 | int:PLCG1 | |
| GeneFamily | Glutamate ionotropic receptor delta type subunits | 1.28e-06 | 2 | 21 | 2 | 1202 | |
| GeneFamily | Transient receptor potential cation channels | 4.34e-06 | 28 | 21 | 3 | 249 | |
| GeneFamily | Nuclear hormone receptors | 1.46e-03 | 49 | 21 | 2 | 71 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.67e-03 | 206 | 21 | 3 | 682 | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-05 | 179 | 35 | 4 | bfc226bcf0b93525992344f968268a261d86fcbf | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-05 | 179 | 35 | 4 | 36ad18f52e175ab636ceaa3be81212fa362c96c1 | |
| ToppCell | tumor_Lung-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 1.43e-05 | 189 | 35 | 4 | 9c407b17d7945e81e1ae6c18452f5d20fb09d563 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.68e-05 | 197 | 35 | 4 | 41dd312f46a2b983c8d864adeb6970c0ca4a8048 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.68e-05 | 197 | 35 | 4 | f66945f9007d59d4208849c7fd727f8519713fbc | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.75e-05 | 199 | 35 | 4 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | LPS_only-Unknown|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.00e-04 | 115 | 35 | 3 | 7a733f6987b40ec497a03734b79ed5355ad3a2fc | |
| ToppCell | LPS_only-Unknown-Endothelial-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.00e-04 | 115 | 35 | 3 | c67145d3cd9243994a141749b426ff2a6dcc8d93 | |
| ToppCell | LPS_only-Unknown-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.00e-04 | 115 | 35 | 3 | ad5298c2ad8bf94fa13c2e50b0799e929473ef59 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Tmem163_Arhgap25|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.06e-04 | 117 | 35 | 3 | e1a14b8413a6f4b194217a90eb2c5f95ab14522e | |
| ToppCell | Enterocyte-C_02|Enterocyte / shred on cell type and cluster | 1.65e-04 | 136 | 35 | 3 | daf11618c65e8fa2d77001b5c277d534cc012a4b | |
| ToppCell | TCGA-Uvea|World / Sample_Type by Project: Shred V9 | 1.83e-04 | 141 | 35 | 3 | 015451a83087f2705d3315ebc8f23797c6f10ed6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.38e-04 | 154 | 35 | 3 | b6e982e341c6cfb6ff80a318078fcb10c36d182f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.38e-04 | 154 | 35 | 3 | d76fd51a4587decbfe1dde1c8a9b880c5fa18e4a | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(NPW+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.42e-04 | 155 | 35 | 3 | 498e52e2364ff44d3c0c707ba22468217031f5bd | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.66e-04 | 160 | 35 | 3 | 8aaf6ac4f33ea291387fdbf9ff1a91d559391774 | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.86e-04 | 164 | 35 | 3 | b6beb8548ac0dd07e8a580a938e5ee4bf25a3c1f | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Mesenchymal-Cilia-bearing_cell|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 2.86e-04 | 164 | 35 | 3 | 346e1530b4bf30adbcb2f7d64fdfb4cd8df69d7f | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.86e-04 | 164 | 35 | 3 | fe11fcce4ba7f44ba2989ea3705916b67e75f8e7 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.91e-04 | 165 | 35 | 3 | cd8de98af8a1a8a6c81d71fae807cc07f319f4c9 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.91e-04 | 165 | 35 | 3 | 4f83ac71efc57be3668d8db1e62bad05dc6a5e2b | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.17e-04 | 170 | 35 | 3 | d70aaa0f4e5034bb9f61b832b5f9123870936d3c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.17e-04 | 170 | 35 | 3 | 5d5f208682be21ed58320f5fc083a7898f8712da | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 3.23e-04 | 171 | 35 | 3 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.28e-04 | 172 | 35 | 3 | 03a0aff6b7971093a4347b5ed12546d78374c56f | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.34e-04 | 173 | 35 | 3 | fd6653d6be9ca6ac36798590694efe03cb758c67 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.40e-04 | 174 | 35 | 3 | 1d157f7a919c8246e83d8060d2a0017c6c781ef3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.45e-04 | 175 | 35 | 3 | d52794426f2703a80e91ae0a8ff2d8e0ce4aa4a8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.45e-04 | 175 | 35 | 3 | 454f03e6109d65f5db08dbb41ecc19ffb6bbc4e0 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.51e-04 | 176 | 35 | 3 | cb21342dd135cc80a50aafe7bf8bf31265db68dd | |
| ToppCell | droplet-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.51e-04 | 176 | 35 | 3 | e2b59a904c5c8f9c88e1e63788e9b6485f22edd0 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.51e-04 | 176 | 35 | 3 | f931192e3cc65414e2245354f443473696cc7ce8 | |
| ToppCell | BAL-Control-Lymphocyte-B|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.51e-04 | 176 | 35 | 3 | 7c1ecec45b5fe5e73cbce0fadca726ffd10c0316 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.57e-04 | 177 | 35 | 3 | 4943d040eee0f9dceaddc7498171281d170e271f | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-04 | 177 | 35 | 3 | 1b153fbfe1323dc589de4af73a52149ea5ce6763 | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-04 | 177 | 35 | 3 | 65709bd546cb1ec6aa2ddd8b2adb46e174eb9a9a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.57e-04 | 177 | 35 | 3 | 3f2272b577c862dba8ccfb41184054bbd0ace6f5 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-04 | 177 | 35 | 3 | 32fecefba1a55e1f418c9a055236fa11175c692d | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-04 | 177 | 35 | 3 | 8684d47a547e2a06496f15e8da0200ecddc431e0 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-04 | 177 | 35 | 3 | dbdbdc8ed9ef0b529694242ef9f9f07a42e16005 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.63e-04 | 178 | 35 | 3 | 185b44700f06ec58b3c09c80520502166c965fd6 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.63e-04 | 178 | 35 | 3 | fba2e38c05cbf031e0c6d47b1602575fea734a57 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.69e-04 | 179 | 35 | 3 | e6ae070b4c52ba08167c7d64ea4cfbac0454c1bf | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-04 | 179 | 35 | 3 | e880c507f11ce75d104593a4ca29f0295f8125e8 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.69e-04 | 179 | 35 | 3 | fa03ec3cc0132f977b4cb28e7b23789732375183 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.69e-04 | 179 | 35 | 3 | f5bb4d3a27d56698473219970e764084096cc582 | |
| ToppCell | renal_papilla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 3.75e-04 | 180 | 35 | 3 | 49829e833fe6d2431cfd2e8f378c2aaa3b2b46a4 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-04 | 180 | 35 | 3 | f6a05b3751b01e74b2de8440801b0eb2e723c199 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-04 | 180 | 35 | 3 | dfc75ae4395ff46fbec2c54915d98ead5a1ba1a1 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-04 | 180 | 35 | 3 | 78fdcfb3fdbf36469cae78407cda5bd0996930d8 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.81e-04 | 181 | 35 | 3 | 451b87ac95154bb80018b8dd245b4a6389d81411 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.87e-04 | 182 | 35 | 3 | af65f0fc3f9e5d9ce69ee5faaf5b6cb7f8412e0c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.87e-04 | 182 | 35 | 3 | b7d532feb73167e05475855061b35a209583f44c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.94e-04 | 183 | 35 | 3 | facd6dbe0851b537d70a899ac7485714ab27d071 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.94e-04 | 183 | 35 | 3 | ba43bca2b45be1008eebd3f033cecb061fb3a966 | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-MK-MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.94e-04 | 183 | 35 | 3 | 9c66a40c355387f805dbdca4162dd05af5c1d8d4 | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.94e-04 | 183 | 35 | 3 | 0e8fb371d8eac777451c76f41d53577f5dfb740d | |
| ToppCell | tumor_Lung-Fibroblasts-Pericytes|tumor_Lung / Location, Cell class and cell subclass | 3.94e-04 | 183 | 35 | 3 | a03dd563af9b15cb1f5de5732a229405a9f82d84 | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.94e-04 | 183 | 35 | 3 | cbc3b00faa7e4e0dbbbc8ee105467c65241c7470 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.00e-04 | 184 | 35 | 3 | 4d4d8f3f44c67d74c57e7af7b7c158f0157b2f49 | |
| ToppCell | megakaryocytic|World / Lineage and Cell class | 4.00e-04 | 184 | 35 | 3 | b1c630ca2189d9d49402a5621b57618976fbea5c | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.00e-04 | 184 | 35 | 3 | f4344f3c407b2d4d703fe56e43d84dbfe60ba833 | |
| ToppCell | COVID-19-Fibroblasts-Pericytes|COVID-19 / group, cell type (main and fine annotations) | 4.06e-04 | 185 | 35 | 3 | 4905adaeeffd353e089578e5ea614437dbe794e6 | |
| ToppCell | COVID-19-Endothelial_cells-Systemic_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 4.06e-04 | 185 | 35 | 3 | f5e14181f45c37d13ee9e017a4c8bc248c353676 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_ISOC1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.06e-04 | 185 | 35 | 3 | ae53aa2ecfe418a5dbd7d963a995bc06dab94f56 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.06e-04 | 185 | 35 | 3 | a7dba7db79275884b2a93d8a16f2e0c739e71370 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Degenerative_Cortical_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.06e-04 | 185 | 35 | 3 | 9438097e94219c1db922b8507e3a29106d32a923 | |
| ToppCell | (5)_Pericytes|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 4.13e-04 | 186 | 35 | 3 | acbca8cc048d87faf859b3e77bdb38d0a3dad71c | |
| ToppCell | (5)_Pericytes-(50)_Pericytes|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 4.13e-04 | 186 | 35 | 3 | 67b59defdd1ed3608229cc5e2a3b480d92312afa | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.13e-04 | 186 | 35 | 3 | 32af3f211f9ad5d5c6b86b83325cfbf2f8466b56 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.19e-04 | 187 | 35 | 3 | 85f1678338a47d91e296f0620d4887f057eb7e70 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.19e-04 | 187 | 35 | 3 | fa01a61bfd13feb033ba1e35cf513707b1bff8c8 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.19e-04 | 187 | 35 | 3 | 86250acf088ec0c4800a0dfa031b0d4f7e52c342 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.19e-04 | 187 | 35 | 3 | 530e4e6d91b5c0d9aa4543caa2b734a1674c5788 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.19e-04 | 187 | 35 | 3 | ec4b694487cc446999c7b27b119950a4f252c4b3 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.19e-04 | 187 | 35 | 3 | 958402fcc78f4c7a7d13d659d776f3817137975f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.19e-04 | 187 | 35 | 3 | 48bfdb3504c3fefe5db3abac4b790c369680ab4e | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.19e-04 | 187 | 35 | 3 | a2bf958ea59c359a265bfa437d59315e1920cdd4 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 4.19e-04 | 187 | 35 | 3 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.26e-04 | 188 | 35 | 3 | 43a3a59f92ad93509d4166bd025aed0b1b39a008 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.26e-04 | 188 | 35 | 3 | ee151792c7ac9afe820f1a281c6dab383799f358 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.26e-04 | 188 | 35 | 3 | ccddc08121caff958a2b6f9e278a018858af6b4d | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.26e-04 | 188 | 35 | 3 | c2321a3a1d9603f8b4b4fc09707eb32ec1e04f3f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.33e-04 | 189 | 35 | 3 | fac5c291a9a87418bb0878c3d624829bdbf1f428 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.33e-04 | 189 | 35 | 3 | 28b502611829e4a24caff2562545c7db97686099 | |
| ToppCell | Mesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor | 4.33e-04 | 189 | 35 | 3 | d7ed96add29f219183c802895fbff519b627f635 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.33e-04 | 189 | 35 | 3 | 3b48b0d220cc24d5170713d61fa91f5bb6c21841 | |
| ToppCell | COVID-19-kidney-PCT-S2|kidney / Disease (COVID-19 only), tissue and cell type | 4.33e-04 | 189 | 35 | 3 | 0be5c669b6b308bd98ddb70c84877c62a6244bbd | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.33e-04 | 189 | 35 | 3 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|World / Lineage and Cell class | 4.39e-04 | 190 | 35 | 3 | 1d19b2bd55789bf13e1386332f46c605973d6f8e | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.39e-04 | 190 | 35 | 3 | 4eb92aef1ee868f4537483d19014d947b7684612 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.39e-04 | 190 | 35 | 3 | 7be4341e2909101d756f14031c21e705eb45e69a | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.39e-04 | 190 | 35 | 3 | 10b02c62e72bfea9767e3e751011436925da823e | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 4.46e-04 | 191 | 35 | 3 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Stroma____kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-04 | 191 | 35 | 3 | 8597a8af294f24496c317d995f07eb5dcc25c13c | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-04 | 191 | 35 | 3 | 5c1f5b6c115b1b27b4a7467a6550ce43c01cf6d0 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.46e-04 | 191 | 35 | 3 | 7b0d42a877540dbb346a76a62403e0d5d3e07fa6 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.46e-04 | 191 | 35 | 3 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.46e-04 | 191 | 35 | 3 | cd854b9c426924fdc84bf7f411f6dea447143e79 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.53e-04 | 192 | 35 | 3 | 24e2f15f5767a97eb3b389922bcfd7b13805e1ce | |
| Drug | Akt inhibitor IV | 4.31e-08 | 24 | 34 | 4 | CID002326992 | |
| Drug | triphosphoinositide | 1.35e-07 | 273 | 34 | 7 | CID009543520 | |
| Drug | Goserelin | 4.04e-07 | 41 | 34 | 4 | CID000047725 | |
| Drug | 4-HT | 4.74e-07 | 105 | 34 | 5 | CID005284643 | |
| Drug | MMEA | 4.98e-07 | 11 | 34 | 3 | CID000125823 | |
| Drug | sodium | SLC47A1 GRID1 GRID2 AKT1 PRKCI RPSA PRKCZ TRPC3 TRPC6 KCNJ13 | 7.57e-07 | 944 | 34 | 10 | CID000000923 |
| Drug | PKI166 | 7.70e-07 | 48 | 34 | 4 | CID006918403 | |
| Drug | LY294002 | 1.07e-06 | 748 | 34 | 9 | CID000003973 | |
| Drug | 2-aminoethyl diphenylborinate | 1.22e-06 | 127 | 34 | 5 | CID000001598 | |
| Drug | 1-oleoyl-2-acetylglycerol | 1.37e-06 | 15 | 34 | 3 | ctd:C038237 | |
| Drug | bufalin | 2.04e-06 | 61 | 34 | 4 | ctd:C022777 | |
| Drug | DEAP-C16Y peptide | 2.16e-06 | 2 | 34 | 2 | ctd:C000609387 | |
| Drug | barium | 2.59e-06 | 148 | 34 | 5 | CID000104810 | |
| Drug | ML 9 | 2.90e-06 | 19 | 34 | 3 | ctd:C056218 | |
| Drug | strontium | 3.15e-06 | 68 | 34 | 4 | CID000104798 | |
| Drug | decanamide | 3.92e-06 | 161 | 34 | 5 | CID000075347 | |
| Drug | 4,4'-bisphenol F | 4.93e-06 | 76 | 34 | 4 | ctd:C008745 | |
| Drug | mangrove | 4.93e-06 | 468 | 34 | 7 | CID000000965 | |
| Drug | AC1L1BDQ | 5.56e-06 | 173 | 34 | 5 | CID000001394 | |
| Drug | Clenbuterol | 6.03e-06 | 24 | 34 | 3 | ctd:D002976 | |
| Drug | 2-(((3,5-dichlorophenyl)carbamoyl)oxy)-2-methyl-3-butenoic acid | 6.49e-06 | 3 | 34 | 2 | ctd:C101851 | |
| Drug | Nafoxidine | 6.49e-06 | 3 | 34 | 2 | ctd:D009256 | |
| Drug | p-tert-amylphenol | 6.49e-06 | 3 | 34 | 2 | ctd:C019566 | |
| Drug | Chromans | 6.49e-06 | 3 | 34 | 2 | ctd:D002839 | |
| Drug | 2,4,6-trichlorophenyl-4'-aminophenyl ether | 6.49e-06 | 3 | 34 | 2 | ctd:C067259 | |
| Drug | 4-hydroxybenzophenone | 6.49e-06 | 3 | 34 | 2 | ctd:C024292 | |
| Drug | versalide | 6.49e-06 | 3 | 34 | 2 | ctd:C023054 | |
| Drug | irilone | 6.49e-06 | 3 | 34 | 2 | ctd:C530234 | |
| Drug | undecan-2-one | 6.49e-06 | 3 | 34 | 2 | ctd:C526928 | |
| Drug | 2,2',4,4',5-brominated diphenyl ether | 7.73e-06 | 26 | 34 | 3 | ctd:C477694 | |
| Drug | glutamate | 8.35e-06 | 962 | 34 | 9 | CID000000611 | |
| Drug | AC1OAGKW | 9.47e-06 | 193 | 34 | 5 | CID006857413 | |
| Drug | 4-hydroxyestradiol | 9.72e-06 | 28 | 34 | 3 | ctd:C014036 | |
| Drug | AC1L1J0H | 1.05e-05 | 197 | 34 | 5 | CID000004813 | |
| Drug | AC1OAGKB | 1.07e-05 | 198 | 34 | 5 | CID006857406 | |
| Drug | 1,3-DCG | 1.15e-05 | 94 | 34 | 4 | CID000150911 | |
| Drug | AC1OAGFB | 1.24e-05 | 539 | 34 | 7 | CID006857345 | |
| Drug | chloropropylate | 1.30e-05 | 4 | 34 | 2 | ctd:C004663 | |
| Drug | phantolid | 1.30e-05 | 4 | 34 | 2 | ctd:C033117 | |
| Drug | isobutyl-4-hydroxybenzoate | 1.30e-05 | 4 | 34 | 2 | ctd:C045922 | |
| Drug | ethyl bromophos | 1.30e-05 | 4 | 34 | 2 | ctd:C041062 | |
| Drug | Phenylphosphonothioic Acid, 2-Ethyl 2-(4-Nitrophenyl) Ester | 1.30e-05 | 4 | 34 | 2 | ctd:D004849 | |
| Drug | dichlofenthion | 1.30e-05 | 4 | 34 | 2 | ctd:C011445 | |
| Drug | chelerythrine | 1.32e-05 | 357 | 34 | 6 | CID000002703 | |
| Drug | NPC 12626 | 1.33e-05 | 31 | 34 | 3 | CID000108099 | |
| Drug | Surfagon | 1.61e-05 | 33 | 34 | 3 | CID005484741 | |
| Drug | damnacanthal | 1.76e-05 | 34 | 34 | 3 | CID000002948 | |
| Drug | Zeranol | 1.93e-05 | 35 | 34 | 3 | ctd:D015029 | |
| Drug | N-methyl-N-(6-methoxy-1-phenyl-1,2,3,4-tetrahydronaphthalen-2-ylmethyl)aminomethylcarboxylic acid | 1.93e-05 | 35 | 34 | 3 | ctd:C520612 | |
| Drug | salvianolic acid B | 1.93e-05 | 35 | 34 | 3 | ctd:C076944 | |
| Drug | nilutamide | 2.10e-05 | 36 | 34 | 3 | CID000004493 | |
| Drug | tolclofos-methyl | 2.16e-05 | 5 | 34 | 2 | ctd:C426783 | |
| Drug | 2,4',5-trichlorobiphenyl | 2.16e-05 | 5 | 34 | 2 | ctd:C015550 | |
| Drug | prothiophos | 2.16e-05 | 5 | 34 | 2 | ctd:C032072 | |
| Drug | isobutylparaben | 2.16e-05 | 5 | 34 | 2 | ctd:C471067 | |
| Drug | 3',5'-dichloro-2-hydroxy-2-methylbut-3-enanilide | 2.16e-05 | 5 | 34 | 2 | CID000115209 | |
| Drug | rifapentine | 2.16e-05 | 5 | 34 | 2 | ctd:C018421 | |
| Drug | 3-benzylidene camphor | 2.16e-05 | 5 | 34 | 2 | ctd:C511303 | |
| Drug | Leptophos | 2.16e-05 | 5 | 34 | 2 | ctd:D010773 | |
| Drug | Norethynodrel | 2.16e-05 | 5 | 34 | 2 | ctd:D009641 | |
| Drug | ethion | 2.16e-05 | 5 | 34 | 2 | ctd:C100038 | |
| Drug | HU-211 | 2.46e-05 | 114 | 34 | 4 | CID000107778 | |
| Drug | bis(4-hydroxyphenyl)sulfone | 2.55e-05 | 401 | 34 | 6 | ctd:C543008 | |
| Drug | trans-3,4,5-trihydroxystilbene | 2.69e-05 | 608 | 34 | 7 | CID000005056 | |
| Drug | tautomycin | 2.82e-05 | 118 | 34 | 4 | CID000440646 | |
| Drug | fadrozole | 2.89e-05 | 40 | 34 | 3 | CID000059693 | |
| Drug | ET-18-OCH3 | 3.01e-05 | 120 | 34 | 4 | CID000001392 | |
| Drug | Factrel | 3.05e-05 | 246 | 34 | 5 | CID000036523 | |
| Drug | 3',5'-dichloro-2-hydroxy-2-methylbut-3-enanilide | 3.23e-05 | 6 | 34 | 2 | ctd:C101850 | |
| Drug | 2',3',4',5'-tetrachloro-4-biphenylol | 3.23e-05 | 6 | 34 | 2 | ctd:C104006 | |
| Drug | nilutamide | 3.23e-05 | 6 | 34 | 2 | ctd:C021277 | |
| Drug | isopropyl 4,4'-dibromobenzilate | 3.23e-05 | 6 | 34 | 2 | ctd:C038267 | |
| Drug | quercetagetin | 3.23e-05 | 6 | 34 | 2 | ctd:C079163 | |
| Drug | tetralin | 3.23e-05 | 6 | 34 | 2 | ctd:C095210 | |
| Drug | LSOs | 3.42e-05 | 124 | 34 | 4 | CID000164701 | |
| Drug | AC1L1K7T | 3.44e-05 | 632 | 34 | 7 | CID000005376 | |
| Drug | SC-9 | 3.60e-05 | 43 | 34 | 3 | CID000124172 | |
| Drug | Hypertensin II | 3.72e-05 | 429 | 34 | 6 | CID000025476 | |
| Drug | AC1ND2OB | 4.34e-05 | 265 | 34 | 5 | CID004568637 | |
| Drug | triphenylethylene | 4.42e-05 | 46 | 34 | 3 | CID000006025 | |
| Drug | melatonin | 4.44e-05 | 443 | 34 | 6 | CID000000896 | |
| Drug | docetaxel | 4.50e-05 | 133 | 34 | 4 | ctd:C067311 | |
| Drug | pendimethalin | 4.52e-05 | 7 | 34 | 2 | ctd:C030856 | |
| Drug | 3,5-dichlorobiphenyl | 4.52e-05 | 7 | 34 | 2 | ctd:C029904 | |
| Drug | ethyl myristate | 4.52e-05 | 7 | 34 | 2 | ctd:C032396 | |
| Drug | octyldimethyl-p-aminobenzoic acid | 4.52e-05 | 7 | 34 | 2 | CID000042851 | |
| Drug | (N)-methanocarba-2MeSADP | 4.52e-05 | 7 | 34 | 2 | ctd:C511689 | |
| Drug | Epirubicin | 4.72e-05 | 47 | 34 | 3 | ctd:D015251 | |
| Drug | ALA-10 | 4.72e-05 | 47 | 34 | 3 | CID003039342 | |
| Drug | AC1L1B55 | 5.09e-05 | 454 | 34 | 6 | CID000001287 | |
| Drug | Hydrocarbons, Chlorinated | 5.35e-05 | 49 | 34 | 3 | ctd:D006843 | |
| Drug | NSC150531 | 5.35e-05 | 49 | 34 | 3 | CID000004475 | |
| Drug | di-n-octyl phthalate | 6.03e-05 | 8 | 34 | 2 | ctd:C010715 | |
| Drug | 1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one | 6.03e-05 | 8 | 34 | 2 | ctd:C532657 | |
| Drug | 1-oleoyl-2-acetoyl-sn-glycerol | 6.03e-05 | 8 | 34 | 2 | ctd:C520323 | |
| Drug | CDRI 85-287 | 6.03e-05 | 8 | 34 | 2 | ctd:C066624 | |
| Drug | tolclofos-methyl | 6.03e-05 | 8 | 34 | 2 | CID000091664 | |
| Drug | MolPort-016-580-972 | 6.03e-05 | 51 | 34 | 3 | CID009938589 | |
| Drug | NSC98537 | 6.39e-05 | 473 | 34 | 6 | CID000005410 | |
| Drug | N-desmethyl-tamoxifen-hydrochloride | 6.40e-05 | 52 | 34 | 3 | CID000035887 | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 1.80e-09 | 105 | 33 | 6 | DOID:9352 (implicated_via_orthology) | |
| Disease | prostate cancer (is_implicated_in) | 1.95e-07 | 117 | 33 | 5 | DOID:10283 (is_implicated_in) | |
| Disease | nicotine dependence (implicated_via_orthology) | 2.78e-07 | 12 | 33 | 3 | DOID:0050742 (implicated_via_orthology) | |
| Disease | Bipolar Disorder | 8.20e-07 | 477 | 33 | 7 | C0005586 | |
| Disease | arrhythmogenic right ventricular dysplasia 5 (implicated_via_orthology) | 1.21e-06 | 2 | 33 | 2 | DOID:0110074 (implicated_via_orthology) | |
| Disease | prostate adenocarcinoma (is_implicated_in) | 1.43e-06 | 20 | 33 | 3 | DOID:2526 (is_implicated_in) | |
| Disease | malignant astrocytoma (is_marker_for) | 2.22e-06 | 23 | 33 | 3 | DOID:3069 (is_marker_for) | |
| Disease | hypertension (implicated_via_orthology) | 1.25e-05 | 128 | 33 | 4 | DOID:10763 (implicated_via_orthology) | |
| Disease | high grade glioma (implicated_via_orthology) | 1.64e-05 | 44 | 33 | 3 | DOID:3070 (implicated_via_orthology) | |
| Disease | leiomyoma (is_implicated_in) | 1.81e-05 | 6 | 33 | 2 | DOID:127 (is_implicated_in) | |
| Disease | hypospadias (is_implicated_in) | 3.38e-05 | 8 | 33 | 2 | DOID:10892 (is_implicated_in) | |
| Disease | Prostatic Intraepithelial Neoplasias | 6.63e-05 | 11 | 33 | 2 | C0282612 | |
| Disease | Colorectal Carcinoma | 1.14e-04 | 702 | 33 | 6 | C0009402 | |
| Disease | Adenocarcinoma of large intestine | 1.70e-04 | 96 | 33 | 3 | C1319315 | |
| Disease | Mental Depression | 1.80e-04 | 254 | 33 | 4 | C0011570 | |
| Disease | Adenocarcinoma of prostate | 2.28e-04 | 20 | 33 | 2 | C0007112 | |
| Disease | Colorectal Neoplasms | 2.51e-04 | 277 | 33 | 4 | C0009404 | |
| Disease | in situ carcinoma (is_marker_for) | 2.51e-04 | 21 | 33 | 2 | DOID:8719 (is_marker_for) | |
| Disease | Depressive disorder | 2.95e-04 | 289 | 33 | 4 | C0011581 | |
| Disease | Neoplasm of the genitourinary tract | 3.30e-04 | 24 | 33 | 2 | cv:C0042065 | |
| Disease | HDL cholesterol change measurement | 3.30e-04 | 24 | 33 | 2 | EFO_0007805 | |
| Disease | Cerebral Astrocytoma | 3.58e-04 | 25 | 33 | 2 | C0750935 | |
| Disease | Intracranial Astrocytoma | 3.58e-04 | 25 | 33 | 2 | C0750936 | |
| Disease | Pilocytic Astrocytoma | 3.58e-04 | 25 | 33 | 2 | C0334583 | |
| Disease | Astrocytoma | 3.58e-04 | 25 | 33 | 2 | C0004114 | |
| Disease | Juvenile Pilocytic Astrocytoma | 3.58e-04 | 25 | 33 | 2 | C0280783 | |
| Disease | Diffuse Astrocytoma | 3.58e-04 | 25 | 33 | 2 | C0280785 | |
| Disease | Grade I Astrocytoma | 3.58e-04 | 25 | 33 | 2 | C1704230 | |
| Disease | Subependymal Giant Cell Astrocytoma | 3.58e-04 | 25 | 33 | 2 | C0205768 | |
| Disease | Mixed oligoastrocytoma | 3.58e-04 | 25 | 33 | 2 | C0547065 | |
| Disease | Childhood Cerebral Astrocytoma | 3.58e-04 | 25 | 33 | 2 | C0338070 | |
| Disease | Gemistocytic astrocytoma | 3.88e-04 | 26 | 33 | 2 | C0334581 | |
| Disease | Protoplasmic astrocytoma | 3.88e-04 | 26 | 33 | 2 | C0334580 | |
| Disease | Fibrillary Astrocytoma | 3.88e-04 | 26 | 33 | 2 | C0334582 | |
| Disease | Anaplastic astrocytoma | 4.18e-04 | 27 | 33 | 2 | C0334579 | |
| Disease | Hyalinosis, Segmental Glomerular | 4.50e-04 | 28 | 33 | 2 | C0086432 | |
| Disease | Subfertility, Female | 4.50e-04 | 28 | 33 | 2 | C0341869 | |
| Disease | Sterility, Postpartum | 4.50e-04 | 28 | 33 | 2 | C0038279 | |
| Disease | ovarian carcinoma (is_marker_for) | 4.50e-04 | 28 | 33 | 2 | DOID:4001 (is_marker_for) | |
| Disease | Female sterility | 4.50e-04 | 28 | 33 | 2 | C0917730 | |
| Disease | Female infertility | 4.50e-04 | 28 | 33 | 2 | C0021361 | |
| Disease | Neoplasm of uncertain or unknown behavior of ovary | 4.83e-04 | 29 | 33 | 2 | C0496920 | |
| Disease | Ovarian Carcinoma | 5.17e-04 | 30 | 33 | 2 | C0029925 | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 5.92e-04 | 147 | 33 | 3 | DOID:9352 (biomarker_via_orthology) | |
| Disease | Spinocerebellar Ataxia Type 2 | 6.65e-04 | 34 | 33 | 2 | C0752121 | |
| Disease | Spinocerebellar Ataxia Type 1 | 6.65e-04 | 34 | 33 | 2 | C0752120 | |
| Disease | Spinocerebellar Ataxia Type 5 | 6.65e-04 | 34 | 33 | 2 | C0752123 | |
| Disease | Spinocerebellar Ataxia Type 7 | 6.65e-04 | 34 | 33 | 2 | C0752125 | |
| Disease | Spinocerebellar Ataxia Type 6 (disorder) | 6.65e-04 | 34 | 33 | 2 | C0752124 | |
| Disease | Ataxia, Spinocerebellar | 6.65e-04 | 34 | 33 | 2 | C0087012 | |
| Disease | Spinocerebellar Ataxia Type 4 | 7.05e-04 | 35 | 33 | 2 | C0752122 | |
| Disease | Parkinson's disease (implicated_via_orthology) | 7.17e-04 | 157 | 33 | 3 | DOID:14330 (implicated_via_orthology) | |
| Disease | endometrial cancer (is_implicated_in) | 7.46e-04 | 36 | 33 | 2 | DOID:1380 (is_implicated_in) | |
| Disease | colon cancer (is_implicated_in) | 7.46e-04 | 36 | 33 | 2 | DOID:219 (is_implicated_in) | |
| Disease | Focal glomerulosclerosis | 7.46e-04 | 36 | 33 | 2 | C0017668 | |
| Disease | ductal carcinoma in situ (is_marker_for) | 8.76e-04 | 39 | 33 | 2 | DOID:0060074 (is_marker_for) | |
| Disease | cardioembolic stroke | 9.03e-04 | 170 | 33 | 3 | EFO_1001976 | |
| Disease | invasive ductal carcinoma (is_marker_for) | 9.21e-04 | 40 | 33 | 2 | DOID:3008 (is_marker_for) | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 9.68e-04 | 41 | 33 | 2 | C0496956 | |
| Disease | Breast adenocarcinoma | 9.68e-04 | 41 | 33 | 2 | C0858252 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DWWGLGVVMYEMMCG | 331 | P31749 | |
| VDWWGLGVVMYEMMC | 331 | P31751 | |
| MMWNWMVSLLATGAA | 336 | Q86V21 | |
| MTMMGLRESAFWLSW | 256 | Q8IUA7 | |
| WDMQMDGRMAKYWLP | 176 | Q8TDX5 | |
| AVDWWGLGVVMYEMM | 326 | Q9Y243 | |
| WDMPWILMLLLTMGQ | 231 | Q5SQ64 | |
| WWALGVLMFEMMAGR | 436 | P41743 | |
| LESCWMEVLMMGLMW | 331 | Q92731 | |
| TTLATRMMMGAWWLF | 626 | O43424 | |
| RMMMGAWWLFALIVI | 631 | O43424 | |
| MALAMLRDWCRWMGA | 1 | A0A0J9YXQ4 | |
| GILMDMRWRWMMLVF | 46 | O60928 | |
| MRWRWMMLVFSASFV | 51 | O60928 | |
| SWMGLMVFAMGWRSF | 741 | P10275 | |
| MTWSMFAVGWMELKD | 536 | Q32M88 | |
| MWEVMAFGERPYWDM | 836 | Q5JZY3 | |
| VAWTWAGGSVMGMMV | 146 | O60404 | |
| IAMVLVNMFGVMWLW | 1131 | O15118 | |
| WMGAWLCLMMQPSHL | 606 | O14981 | |
| NSMAMRIVMGSWWLF | 626 | Q9ULK0 | |
| MGMWASLDALWEMPA | 1 | O75844 | |
| VGLMWWMLAREVLRM | 171 | P08865 | |
| EMMAQAGSLEWMSLW | 1336 | Q86VV8 | |
| WLRWRMNGMIVMLLI | 121 | Q7RTR8 | |
| MKTWGLRAAGWMAMF | 306 | Q9BTV4 | |
| WRWIFIMVCSEMKGM | 361 | Q4G0N8 | |
| WMFGVCMWEILMHGV | 606 | Q05397 | |
| MAGMALARAWKQMSW | 1 | Q969W0 | |
| SMLMLCMEWWAYEVG | 266 | Q96FL8 | |
| MAVTMLQDWCRWMGV | 1 | P0CW24 | |
| VGWIMSIFWGMDMVI | 111 | Q69YW2 | |
| WMGDFVTAWMVTDMM | 161 | Q9H0C3 | |
| FSWMEMLIISWVIGM | 491 | Q9Y210 | |
| WRMMNFRQRMGWIGV | 31 | Q8N6I4 | |
| EMLIMVWVLGMMWSE | 426 | Q13507 | |
| FSWTEMLIMKWVLGM | 436 | Q9HCX4 | |
| SVDWWALGVLMFEMM | 431 | Q05513 |